{{Rsnum
|rsid=2352904
|Chromosome=14
|position=48903598
|Orientation=plus
|GMAF=0.4936
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 13.8 | 44.6 | 41.5
| HCB | 26.2 | 47.6 | 26.2
| JPT | 13.6 | 70.5 | 15.9
| YRI | 23.2 | 51.8 | 25.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 26.2 | 47.6 | 26.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs2352904
|PubMedID=17903297
|Condition=Cognitive test performance
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PMID|17903297|OA=1
}} non sig. gwas, top 25 GEE p-values, visual memory and organization

{{PharmGKB
|RSID=rs2352904
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903297; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study (Initial Sample Size: 705 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Cognitive test performance.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356439
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2352904
|overall_frequency_n=74
|overall_frequency_d=128
|overall_frequency=0.578125
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=65
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}